Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma

There are many reports on paclitaxel, ifosfamide, and cisplatin (TIP) therapy, following standard bleomycin, etoposide, and cisplatin (BEP) therapy, for salvage treatment of testicular malignant germ cell tumors, but there are no reports on its use for ovarian malignant tumors. We report here that a...

Full description

Saved in:
Bibliographic Details
Published in:The journal of obstetrics and gynaecology research 2016, Vol.42 (11), p.1613-1617
Main Authors: Hino, Makiko, Kobayashi, Yusuke, Wada, Michiko, Hattori, Yoshihisa, Kurahasi, Takashi, Nakagawa, Hiroyuki
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There are many reports on paclitaxel, ifosfamide, and cisplatin (TIP) therapy, following standard bleomycin, etoposide, and cisplatin (BEP) therapy, for salvage treatment of testicular malignant germ cell tumors, but there are no reports on its use for ovarian malignant tumors. We report here that a patient with primary ependymoma of the ovary, who was resistant to BEP therapy, achieved a complete response to a combined therapy, including TIP therapy as the second-line chemotherapy and surgery. This important case, combined with published studies, suggests that TIP therapy is effective for both testicular and ovarian malignant tumors and indicates that TIP therapy can be used as an effective second-line therapy for malignant tumors resistant to BEP therapy.
ISSN:1447-0756
DOI:10.1111/jog.13084